Independientemente del tipo de seguro de salud que tenga, o incluso si no tiene ninguno, hay algunas posibles opciones disponibles para ayudarle a costear su medicamento.
Para hablar sobre posibles opciones en español
Llámenos al 877-GENENTECH (877-436-3683) (de 6 a.m. a 5 p.m. hora del Pacífico, de lunes a viernes).
Enlaces Rápidos
Programa de Copago de Pulmozyme y Derivaciones a Fundaciones Independientes de Asistencia con los Copagos
Si tiene cobertura de seguro y necesita ayuda para cubrir el costo de Pulmozyme, estos programas pueden brindarle ayuda:
Ayuda con los costos de Pulmozyme
Programa de Copago de Pulmozyme puede ayudarlo con los gastos de bolsillo de su medicamento de Genentech, si usted es elegible.
El Programa de Copago de Pulmozyme ayuda a pacientes con seguros de salud comerciales. Puede tratarse de un plan que obtiene a través de su empleador o uno que haya contratado en un Mercado de Seguros Médicos. Para poder calificar, también debe cumplir otros requisitos.
Llame al Programa de Copago de Pulmozyme al 877-GENENTECH (877-436-3683) para obtener más información.
Aplican criterios de elegibilidad. No válido para pacientes que utilizan programas del gobierno federal o estatal para pagar sus medicamentos de Genentech. Los pacientes deben estar tomando el medicamento de Genentech para una indicación aprobada por la FDA. Visite el sitio web del Programa de Copagos para ver la lista completa de Términos y Condiciones.
Una fundación independiente de asistencia con los copagos es una organización benéfica que brinda asistencia financiera a pacientes con estados de enfermedad específicos, independientemente del tratamiento. Los pacientes que tienen seguro comercial o público, incluyendo a los pacientes con cobertura de Medicare y Medicaid, pueden comunicarse directamente con las fundaciones para solicitar asistencia. Los requisitos de elegibilidad, todos los aspectos del proceso de solicitud, los tiempos de entrega y el tipo o el monto de la asistencia que se ofrece (de existir) pueden variar según la fundación.
Estas organizaciones son independientes con respecto a Genentech y pueden solicitarle que proporcione su información personal o financiera directamente a las organizaciones para inscribirse en sus respectivos programas. Genentech no puede compartir ningún dato que nos haya provisto a nosotros.
Llame al Pulmozyme Access Solutions al 877-GENENTECH (877-436-3683) para obtener más información.
Las fundaciones independientes de asistencia con el copago tienen sus propias normas de elegibilidad. No tenemos participación ni ejercemos influencia en la toma de decisiones ni en los criterios de elegibilidad de las fundaciones independientes; tampoco sabemos si una fundación podrá brindarle ayuda. Solo podemos derivarle a una fundación que le asista con su estado de salud. Esta información solo se la proporcionamos a modo informativo. No respaldamos ni mostramos preferencia por ninguna fundación en particular.
La Fundación de Pacientes de Genentech
Si tiene dificultades financieras o no cuenta con una cobertura de seguro y necesita ayuda para costear Pulmozyme, este programa podría ayudarle:
La Fundación de Pacientes de Genentech otorga Pulmozyme gratuito a personas a las que se le hayan recetado este medicamento y no tengan seguro o tengan problemas financieros y cumplan con ciertos criterios de elegibilidad.
Si cuenta con un seguro de salud, debería intentar obtener otros tipos de asistencia financiera, si se encuentran disponibles. También debe cumplir con los requisitos de ingresos. Si no tiene seguro o si su seguro no cubre sus medicamentos de Genentech, debe cumplir con una serie de distintos requisitos de ingresos.
Llame al Pulmozyme Access Solutions al 877-GENENTECH (877-436-3683) para obtener más información.
Genentech se reserva el derecho a modificar o interrumpir el programa en cualquier momento y a verificar la exactitud de la información presentada.
Para hablar sobre posibles opciones en español
Llámenos al 877-GENENTECH (877-436-3683) (de 6 a.m. a 5 p.m. hora del Pacífico, de lunes a viernes).
-
Seguro comercial: Un plan de seguros que se contrata con una compañía de seguros de salud privada. Puede ser un plan vinculado a su trabajo o uno que haya contratado en un Mercado de Seguros Médicos. Medicare y Medicaid no entran en la definición de seguro comercial.
-
Seguro público: Un plan de seguro de salud que obtiene del gobierno federal o estatal. Esto incluye Medicare, Medicaid, TRICARE y el seguro DoD/VA.
Terms and Conditions
The Product and Administration Co-pay Programs are valid ONLY for patients with commercial (private or non-governmental) insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medicine. Patients using Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD), TRICARE or any other federal or state government program (collectively, “Government Programs”) to pay for their Genentech medicine and/or administration services are not eligible. The Programs are not valid if the costs are eligible to be reimbursed in their entirety by private insurance plans or other programs.
Under the Programs, the patient may pay a co-pay. The final amount owed by a patient may be as little as $0 for the Genentech medicine or administration of the Genentech medicine (see Program specific details). The total patient out-of-pocket cost is dependent on the patient’s health insurance plan. The Programs assist with the cost of the Genentech medicine and the Genentech medicine administration only. It does not assist with the cost of other administrations, medicines, procedures or office visit fees. After reaching the maximum Programs’ benefit amounts, the patient will be responsible for all remaining out-of-pocket expenses. The Programs’ benefit amounts cannot exceed the patient’s out-of-pocket expenses for the cost of the Genentech medicine or administration fees associated with the Genentech medicine. The maximum Programs’ benefits will reset every January 1st. The Programs are not health insurance or a benefit plan. The patient’s non-governmental insurance is the primary payer. The Programs do not obligate use of any specific medicine or provider. The Drug Co-pay Program is not available or valid for patients receiving free medicine from the Genentech Patient Foundation. The Administration Co-pay Program is valid for patients receiving free medicine from the Genentech Patient Foundation. The Product and Administration Programs are not valid for patients receiving assistance from any other charitable organization for the same expenses covered by the Programs. The Programs’ benefits cannot be combined with any other rebate, free trial or similar offer for the Genentech medicine or administration of the Genentech medicine. No party may seek reimbursement for all or any part of the benefits received through these Programs.
The Programs may be accepted by participating pharmacies, physicians’ offices or hospitals. Once a patient is enrolled, the Programs will honor claims with a date of service that precedes the Programs’ enrollment by 180 days. Claims must be submitted within 365 days from the date of service unless otherwise indicated. Use of these Programs must be consistent with all relevant health insurance requirements. Participating patients, pharmacies, physicians’ offices and hospitals are responsible for reporting the receipt of all the Programs’ benefits as required by any insurer or by law. Program benefits may not be sold, purchased, traded or offered for sale.
The patient or their guardian must be 18 years of age or older to receive assistance from the Programs. The Programs are only valid in the United States and U.S. Territories and are void where prohibited by law. The Drug Co-pay Program shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. The Administration Co-pay Program is not valid for Massachusetts or Rhode Island residents. Eligible patients will be automatically re-enrolled in the Programs on an annual basis. Eligible patients will be removed from the Programs after 3 years of inactivity (e.g., no claims submitted in a 3-year timeframe). Programs eligibility and automatic re-enrollment are contingent upon the patient’s ability to meet all the requirements set forth by the Programs. Healthcare providers may not advertise or otherwise use the Programs as a means of promoting their services or Genentech medicines to patients. The Programs are intended for the patient. Only the patient using the Programs may receive the funds made available through the Programs. The Programs are not intended for third parties who reduce the amount available to the patient or take a portion for their own purposes. Patients with health plans that redirect Genentech Program assistance intended for patient out-of-pocket costs may be subject to alternate Program benefit structures. Genentech reserves the right to rescind, revoke or amend the Programs without notice at any time.
Terms and Conditions
The Co-pay Program is valid ONLY for patients with commercial (private or non-governmental) insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medicine. Patients using Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD), TRICARE or any other federal or state government program (collectively, “Government Programs”) to pay for their Genentech medicine are not eligible. The Program is not valid for Genentech medicines that are eligible to be reimbursed in their entirety by private insurance plans or other programs.
Under the Program, the patient may pay a co-pay. The final amount owed by a patient may be as little as $0 for the Genentech medicine (see Program specific details). The total patient out-of-pocket cost is dependent on the patient’s health insurance plan. The Program assists with the cost of the Genentech medicine only. It does not assist with the cost of other medicines, procedures or office visit fees. After reaching the maximum annual Program benefit amount, the patient will be responsible for all remaining out-of-pocket expenses. The Program benefit amount cannot exceed the patient’s out-of-pocket expenses for the cost associated with the Genentech medicine. The maximum Program benefit will reset every January 1st. The Program is not health insurance or a benefit plan. The patient’s non-governmental insurance is the primary payer. The Program does not obligate the use of any specific medicine or provider. Patients receiving assistance from charitable free medicine programs (such as the Genentech Patient Foundation) or any other charitable organizations for the same expenses covered by the Program are not eligible. The Program benefit cannot be combined with any other rebate, free trial or a similar offer for the Genentech medicine. No party may seek reimbursement for all or any part of the benefit received through the Program.
The Program may be accepted by participating pharmacies, physicians’ offices or hospitals. Once a patient is enrolled, the Program will honor claims with a date of service that precedes the Program enrollment date up to 180 days. Claims must be submitted within 365 days from the date of service unless otherwise indicated. Use of the Program must be consistent with all relevant health insurance requirements. Participating patients, pharmacies, physicians’ offices and hospitals are responsible for reporting the receipt of all Program benefits as required by any insurer or by law. Program benefits may not be sold, purchased, traded or offered for sale.
The patient or their guardian must be 18 years of age or older to receive Program assistance. The Program is only valid in the United States and U.S. Territories, is void where prohibited by law and shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. Eligible patients will be automatically re-enrolled in the Program on an annual basis. Eligible patients will be removed from the Program after 3 years of inactivity (e.g., no claims submitted in a 3-year timeframe). Program eligibility and automatic re-enrollment are contingent upon the patient’s ability to meet all requirements set forth by the Program. Healthcare providers may not advertise or otherwise use the Program as a means of promoting their services or Genentech medicines to patients. The Program is intended for the patient. Only the patient using the Program may receive the funds made available through the Program. The Program is not intended for third parties who reduce the amount available to the patient or take a portion for their own purposes. Patients with health plans that redirect Genentech Program assistance intended for patient out-of-pocket costs may be subject to alternate Program benefit structures. Genentech reserves the right to rescind, revoke or amend the Program without notice at any time.